Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
Australia
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 2,6 Dichlorobenzylideneaminoguanidine
2. 2,6-dichlorobenzylideneaminoguanidine
3. Acetate Wyeth-ayerst, Guanabenz
4. Acetate, Guanabenz
5. Br 750
6. Br-750
7. Br750
8. Guanabenz
9. Guanabenz Acetate
10. Guanabenz Acetate Wyeth-ayerst
11. Guanabenz Monoacetate
12. Monoacetate, Guanabenz
13. Wy 8678
14. Wy-8678
15. Wy8678
16. Wyeth Ayerst Of Guanabenz Acetate
17. Wyeth-ayerst Of Guanabenz Acetate
18. Wytensin
1. Guanabenz
2. 5051-62-7
3. Hydrazinecarboximidamide, 2-[(2,6-dichlorophenyl)methylene]-, (e)-
4. Dsstox_cid_25666
5. Dsstox_rid_81042
6. Dsstox_gsid_45666
7. Cas-5051-62-7
8. Ncgc00024846-03
9. Spectrum_000843
10. Prestwick0_000096
11. Prestwick1_000096
12. Spectrum2_001114
13. Spectrum3_000445
14. Spectrum4_000567
15. Kbiogr_000974
16. Kbioss_001323
17. Divk1c_000010
18. Spbio_001248
19. Spbio_001991
20. Chembl1313657
21. Dtxsid6045666
22. Kbio1_000010
23. Kbio2_001323
24. Kbio2_003891
25. Kbio2_006459
26. Kbio3_001310
27. Ninds_000010
28. Hms2233d12
29. Hms3370a17
30. Bcp30851
31. Tox21_110932
32. Akos017264577
33. Tox21_110932_1
34. Zinc242701441
35. Db00629
36. 2,6-dichlorobenzaldehyde Guanylhydrazone
37. Mrf-0000008
38. Ncgc00024846-08
39. Db-051784
40. Ft-0635524
41. Guanabenzum;wy-8678; Wy 8678; Wy8678
42. N-(2,6-dichlorobenzylidene)-n'-amidino Hydrazine
43. Sr-01000721838
44. Sr-01000721838-5
45. Q27164730
Molecular Weight | 231.08 g/mol |
---|---|
Molecular Formula | C8H8Cl2N4 |
XLogP3 | 1.7 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 2 |
Rotatable Bond Count | 2 |
Exact Mass | 230.0126017 g/mol |
Monoisotopic Mass | 230.0126017 g/mol |
Topological Polar Surface Area | 76.8 Ų |
Heavy Atom Count | 14 |
Formal Charge | 0 |
Complexity | 228 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 1 |
Covalently Bonded Unit Count | 1 |
For management of High blood pressure
FDA Label
Guanabenz, a centrally acting α-2 adrenergic agonist, is indicated for treatment of hypertension.
Adrenergic alpha-2 Receptor Agonists
Compounds that bind to and activate ADRENERGIC ALPHA-2 RECEPTORS. (See all compounds classified as Adrenergic alpha-2 Receptor Agonists.)
Antihypertensive Agents
Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)
Absorption
Approximately 75% absorbed from gastrointestinal tract
Hepatic
6 hours.
Guanabenz's antihypertensive effect is thought to be due to central alpha-adrenergic stimulation, which results in a decreased sympathetic outflow to the heart, kidneys, and peripheral vasculature in addition to a decreased systolic and diastolic blood pressure and a slight slowing of pulse rate. Chronic administration of guanabenz also causes a decrease in peripheral vascular resistance.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 14072
Submission : 1999-04-07
Status : Active
Type : II
NDC Package Code : 66127-100
Start Marketing Date : 2006-04-21
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Registrant Name : Rocket Korea Ltd.
Registration Date : 2024-08-28
Registration Number : 20240828-211-J-1682
Manufacturer Name : ROQUETTE FRERES
Manufacturer Address : 1 Rue de la Haute Loge, 62136 LESTREM, France
Related Excipient Companies
Market Place
Patents & EXCLUSIVITIES
ABOUT THIS PAGE
21
PharmaCompass offers a list of Icodextrin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Icodextrin manufacturer or Icodextrin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Icodextrin manufacturer or Icodextrin supplier.
PharmaCompass also assists you with knowing the Icodextrin API Price utilized in the formulation of products. Icodextrin API Price is not always fixed or binding as the Icodextrin Price is obtained through a variety of data sources. The Icodextrin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Baxter Brand of Icodextrin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Baxter Brand of Icodextrin, including repackagers and relabelers. The FDA regulates Baxter Brand of Icodextrin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Baxter Brand of Icodextrin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Baxter Brand of Icodextrin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Baxter Brand of Icodextrin supplier is an individual or a company that provides Baxter Brand of Icodextrin active pharmaceutical ingredient (API) or Baxter Brand of Icodextrin finished formulations upon request. The Baxter Brand of Icodextrin suppliers may include Baxter Brand of Icodextrin API manufacturers, exporters, distributors and traders.
click here to find a list of Baxter Brand of Icodextrin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Baxter Brand of Icodextrin DMF (Drug Master File) is a document detailing the whole manufacturing process of Baxter Brand of Icodextrin active pharmaceutical ingredient (API) in detail. Different forms of Baxter Brand of Icodextrin DMFs exist exist since differing nations have different regulations, such as Baxter Brand of Icodextrin USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Baxter Brand of Icodextrin DMF submitted to regulatory agencies in the US is known as a USDMF. Baxter Brand of Icodextrin USDMF includes data on Baxter Brand of Icodextrin's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Baxter Brand of Icodextrin USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Baxter Brand of Icodextrin suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Baxter Brand of Icodextrin Drug Master File in Korea (Baxter Brand of Icodextrin KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Baxter Brand of Icodextrin. The MFDS reviews the Baxter Brand of Icodextrin KDMF as part of the drug registration process and uses the information provided in the Baxter Brand of Icodextrin KDMF to evaluate the safety and efficacy of the drug.
After submitting a Baxter Brand of Icodextrin KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Baxter Brand of Icodextrin API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Baxter Brand of Icodextrin suppliers with KDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Baxter Brand of Icodextrin as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Baxter Brand of Icodextrin API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Baxter Brand of Icodextrin as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Baxter Brand of Icodextrin and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Baxter Brand of Icodextrin NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Baxter Brand of Icodextrin suppliers with NDC on PharmaCompass.
Baxter Brand of Icodextrin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Baxter Brand of Icodextrin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Baxter Brand of Icodextrin GMP manufacturer or Baxter Brand of Icodextrin GMP API supplier for your needs.
A Baxter Brand of Icodextrin CoA (Certificate of Analysis) is a formal document that attests to Baxter Brand of Icodextrin's compliance with Baxter Brand of Icodextrin specifications and serves as a tool for batch-level quality control.
Baxter Brand of Icodextrin CoA mostly includes findings from lab analyses of a specific batch. For each Baxter Brand of Icodextrin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Baxter Brand of Icodextrin may be tested according to a variety of international standards, such as European Pharmacopoeia (Baxter Brand of Icodextrin EP), Baxter Brand of Icodextrin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Baxter Brand of Icodextrin USP).